The HELlenic Thoracic Society Initiative for CΟPD and CVD
Recruiting
Observational Study
Chronic Obstructive Pulmonary Disease (COPD)
Cardiovascular Diseases (CVD)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 35 – 99
- Sex
- Any
- Study type
- Observational
- Participants needed
- 900 (estimated)
- Sponsor
- Hellenic Thoracic Society · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
COPD is one of the most common respiratory diseases in Greece, and maybe more than half a million Greek citizens suffer both from COPD and CVD, however their characteristics and management remain unknown. HELICOPD is a national, multicenter, prospective, non-interventional study designed to contribute to better understanding and depicting the demographic and clinical characteristics of this popula…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria
Patients should cumulatively meet the following three (3) criteria to be enrolled in the study:
1. To have been diagnosed with chronic obstructive pulmonary disease and at least one cardiovascular comorbidity (heart failure, atherosclerotic cardiovascular disease, atrial Fibrill…
Contacts